As of 2026-03-08, the EV/EBITDA ratio of G1 Therapeutics Inc (GTHX) is -11.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GTHX's latest enterprise value is 406.48 mil USD. GTHX's TTM EBITDA according to its financial statements is -35.15 mil USD. Dividing these 2 quantities gives us the above GTHX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 15.3x | 14.8x |
| Forward P/E multiples | 16.8x - 20.7x | 18.8x |
| Fair Price | (11.75) - (10.75) | (11.75) |
| Upside | -264.3% - -250.3% | -264.3% |
| Date | EV/EBITDA |